Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar ...

“Previously, patients thought to be eligible for LAIs — also reflected in past guidelines — were chronically ill patients, those with multiple relapses, established nonadherence, or patients ...

If you are worried about using this medicine, speak to your doctor or pharmacist. INVEGA HAFYERA contains the active ingredient paliperidone palmitate. INVEGA HAFYERA is used to treat ...

unsealed ruling shows Schizophrenia drug had nearly $3 billion in US sales in 2023 Johnson & Johnson’s Janssen Pharmaceuticals Inc. unit convinced a federal judge that unexpected results and industry ...